Cavicchioli,Marcelo, Bitencourt,Almir Galvão Vieira, & Lima,Eduardo Nóbrega Pereira. (2022). 68Ga-DOTATATE PET/CT versus 111In-octreotide scintigraphy in patients with neuroendocrine tumors: A prospective study.
Chicago Style CitationCavicchioli,Marcelo, Bitencourt,Almir Galvão Vieira, and Lima,Eduardo Nóbrega Pereira. 68Ga-DOTATATE PET/CT Versus 111In-octreotide Scintigraphy in Patients With Neuroendocrine Tumors: A Prospective Study. 2022.
MLA CitationCavicchioli,Marcelo, Bitencourt,Almir Galvão Vieira, and Lima,Eduardo Nóbrega Pereira. 68Ga-DOTATATE PET/CT Versus 111In-octreotide Scintigraphy in Patients With Neuroendocrine Tumors: A Prospective Study. 2022.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.